During the past decade, Inje University Haeundae Paik Hospital conducted 111 clinical trials. In the 10-year time frame, 111 clinical trials started and 24 clinical trials were completed, i.e. on average, 21.6% percent of trials that started reached the finish line to date. In the past 5 years, 43 clinical trials started and 21 clinical trials were completed. i.e. 48.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Inje University Haeundae Paik Hospital" #1 sponsor was "Inje University" with 19 trials, followed by "Janssen Research & Development, LLC" with 11 trials sponsored, "Boehringer Ingelheim" with 9 trials sponsored, "Celgene" with 8 trials sponsored and "Asan Medical Center" with 8 trials sponsored. Other sponsors include 81 different institutions and companies that sponsored additional 57 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Inje University Haeundae Paik Hospital" #1 collaborator was "Inje University" with 4 trials as a collaborator, "CardioVascular Research Foundation, Korea" with 3 trials as a collaborator, "Incheon St.Mary's Hospital" with 3 trials as a collaborator, "Korean Cancer Study Group" with 3 trials as a collaborator and "Dongnam Institute of Radiological & Medical Sciences" with 2 trials as a collaborator. Other collaborators include 21 different institutions and companies that were collaborators in the rest 29 trials.

According to Clinical.Site data, the most researched conditions in "Inje University Haeundae Paik Hospital" are "Ulcerative Colitis" (12 trials), "Crohn Disease" (9 trials), "Crohn's Disease" (8 trials), "Colitis, Ulcerative" (5 trials) and "Coronary Artery Disease" (5 trials). Many other conditions were trialed in "Inje University Haeundae Paik Hospital" in a lesser frequency.

Most popular intervention types in "Inje University Haeundae Paik Hospital" are "Drug" (111 trials), "Other" (11 trials), "Procedure" (10 trials), "Biological" (7 trials) and "Device" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (30 trials), "Mirikizumab" (4 trials), "Ontamalimab" (4 trials), "Capecitabine" (3 trials) and "Cetrelimab" (3 trials). Other intervention names were less common.

The vast majority of trials in "Inje University Haeundae Paik Hospital" are 134 trials for "All" genders and 6 trials for "Female" genders.

Currently, there are NaN active trials in "Inje University Haeundae Paik Hospital". undefined are not yet recruiting, 28 are recruiting, 24 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 55 completed trials in Inje University Haeundae Paik Hospital, undefined suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in Inje University Haeundae Paik Hospital, 3 "Phase 1" clinical trials were conducted, 23 "Phase 2" clinical trials and 69 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 10 trials, and there were also 12 trials that are defined as “Not Applicable".